Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Conference Correspondent
EHA 2016
EHA 2016 – Leukemia
EHA 2016 – Leukemia
5-Azacitidine plus Checkpoint Inhibitor May Enhance Outcomes in Patients with De Novo and Relapsed AML
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Acalabrutinib, a Second-Generation BTK Inhibitor, Is Active in Previously Untreated CLL
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
ALL – Clinical Oral Presentations: Saturday, June 11
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
ALL – Clinical Poster Session: Friday, June 10
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Blinatumomab Demonstrates Overall Survival Benefit in Adults with Relapsed ALL in the TOWER Study
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
CD19 CAR T Cells Induce Potent Responses and Control CNS Leukemia in Relapsed ALL
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
CLL – Clinical Poster Session: Friday, June 10
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Duration of TKI Treatment and Duration of Deep Molecular Response Affect Relapse-Free Survival in CML
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Higher-Dose Daunorubicin Is Effective in Patients with AML Who Harbor FLT3-ITD Mutations
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Ibrutinib plus Bendamustine and Rituximab (BR) in Previously Treated CLL/SLL: 2-Year Follow-Up Data from the HELIOS Study
EHA 2016
,
EHA 2016 – Leukemia
,
EHA
Conference Correspondent
Read Article
Page 1 of 2
1
2
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
Talvey Receives Accelerated Approval for Relapsed or Refractory Multiple Myeloma
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma